Piper Jaffray was making a market in the securities of Clovis Oncology, Inc. at the time this research report was published. Piper Jaffray will buy and sell Clovis Oncology, Inc. securities on a principal basis.
Taking a look at our overall financial position, in the first quarter we repurchased a total of $317 million worth of shares. We have now spent over $6 billion buying back shares since we began our buyback program at the end of 2010, and we've reduced our outstanding share count by 29% as we continue to find the return on repurchasing our shares very attractive.
Yes indeed he sure does look like he's running out of bullets. Well you can tell how the rich money controls the media in our country as well as lawyers filing bogus lawsuits to influence the stock market. It really runs deep
No slowdown still selling a ton of product